drugset / Trial / NCT02280603

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

NCT02280603

Phase 1/2 Completed 60 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia Design : Randomized, double-blind, active-controlled study Investigational Product : Finasteride, minoxidil

Timeline

Start
2014-01
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-4001C Unknown 1 ml Topical
Comparator Minoxidil Small molecule 1 ml Topical
Comparator Minoxidil Small molecule 5 % Topical

Indications